Christine M Lovly

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Venues

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

medRxiv : the preprint server for health sciences

Vanderbilt University Medical Center

Washington University in Saint Louis School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University Medical Center Jan 01 2019

United States

Associate Professor of Medicine with Tenure :: Department of Medicine, Division of Hematology-Oncology

Vanderbilt University Medical Center

United States

Co-Leader, Translational Research and Interventional Oncology Program :: Vanderbilt Ingram Cancer Center (VICC)

Vanderbilt University Medical Center Jul 01 2013 - Dec 31 2018

United States

Assistant Professor of Medicine, Tenure Track :: Department of Medicine, Division of Hematology-Oncology

Vanderbilt University Medical Center Jul 01 2012 - Jun 30 2013

United States

Instructor in Medicine :: Department of Medicine, Division of Hematology-Oncology

Education History

Washington University in Saint Louis School of Medicine

United States

PHD :: Medicine, Molecular and Cellular Biology

Publications

Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas, Christina J Falcon, null null, Matthew A Gubens, Scott Huntsman, Khaleeq Khan, Min Li, Christine M Lovly, Devalben Patel, Luna Jia Zhan, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events. medRxiv : the preprint server for health sciences (2024)
Claiborne W Tydings, Bhuminder Singh, Adam W Smith, Kaitlyn V Ledwitch, Benjamin P Brown, Christine M Lovly, Allison S Walker, Jens Meiler
Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics. Protein science : a publication of the Protein Society 33 (10) (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas, Christina J Falcon, null null, Matthew A Gubens, Scott Huntsman, Khaleeq Khan, Min Li, Christine M Lovly, Devalben Patel, Luna Jia Zhan, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events. medRxiv : the preprint server for health sciences (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Jessica J Lin, Justin F Gainor, Vincent K Lam, Christine M Lovly
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease. Cancer discovery 14 (6) (2024)
Misty D Shields, Christine M Lovly
Refining neoadjuvant immunotherapy for resectable lung cancer. Nature medicine 30 (6) (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Christine M Lovly
New Benchmark for Targeted Therapies in Lung Cancer: Median Progression-Free Survival for Lorlatinib in Advanced ALK+ Non-Small Cell Lung Cancer Surpasses 5 years. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Misty D Shields, Christine M Lovly
Refining neoadjuvant immunotherapy for resectable lung cancer. Nature medicine (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Misty D Shields, Christine M Lovly
Refining neoadjuvant immunotherapy for resectable lung cancer. Nature medicine 30 (6) (2024)
Christine M Lovly
Perioperative Immunotherapy - A KEY toward Improved Outcomes for Early-Stage Lung Cancer? The New England journal of medicine 389 (6) (2023)
Pashtoon Murtaza Kasi, Jessica K Lee, Lincoln W Pasquina, Brennan Decker, Pierre Vanden Borre, Dean C Pavlick, Justin M Allen, Christine Parachoniak, Julia Coelho França Quintanilha, Ryon P Graf, Alexa B Schrock, Geoffrey R Oxnard, Christine M Lovly, Hanna Tukachinsky, Vivek Subbiah
Circulating tumor DNA enables sensitive detection of actionable gene fusions and rearrangements across cancer types. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Howard Jack West, Christine M Lovly
Reply to J.M. Kolesar et al, J.S. Bates et al, and T.C. Knepper et al. JCO oncology practice (2023)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Luna Jia Zhan, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Genetic prediction of colitis in non-small cell lung cancer patients on immune checkpoint inhibitor therapy. medRxiv : the preprint server for health sciences (2023)
Howard Jack West, Christine M Lovly
Ferrying Oncologists Across the Chasm of Interpreting Biomarker Testing Reports: Systematic Support Needed to Improve Care and Decrease Disparities. JCO oncology practice (2023)
Smruthy S Sivakumar, Jay A Moore, Meagan Montesion, Radwa Sharaf, Douglas I Lin, Caterina I Colón, Zoe Fleischmann, Ericka M Ebot, Justin Y Newberg, Jennifer M Mills, Priti S Hegde, Quintin Pan, Afshin Dowlati, Garrett M Frampton, Julien Sage, Christine M Lovly
Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation. Cancer discovery (2023)
Lavanya Sivapalan, Wade T Iams, Zineb Belcaid, Susan C Scott, Noushin Niknafs, Archana Balan, James Robert White, Prasad R Kopparapu, Christopher Cann, Blair V Landon, Gavin Pereira, Victor E Velculescu, Christine L Hann, Christine M Lovly, Valsamo Anagnostou
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Robert B Scharpf, Archana Balan, Biagio Ricciuti, Jacob Fiksel, Christopher M Cherry, Chenguang Wang, Michele L LeNoue-Newton, Hira A Rizvi, James Robert White, Alexander S Baras, Jordan Anaya, Blair V Landon, Marta Majcherska-Agrawal, Paola Ghanem, Jocelyn Lee, Leon Raskin, Andrew S Park, Huakang Tu, Hilary K Hsu, Kathryn C Arbour, Mark M Awad, Gregory J Riely, Christine M Lovly, Valsamo Anagnostou
Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers. Cancer research 82 (21) (2022)
Lily L Remsing Rix, Natalia J Sumi, Qianqian Hu, Bina Desai, Annamarie T Bryant, Xueli Li, Eric A Welsh, Bin Fang, Fumi Kinose, Brent M Kuenzi, Yian Ann Chen, Scott J Antonia, Christine M Lovly, John M Koomen, Eric B Haura, Andriy Marusyk, Uwe Rix
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells. Science signaling 15 (747) (2022)
Hiroki Sato, Daisuke Kubota, Huan Qiao, Achim Jungbluth, Natasha Rekhtman, Adam J Schoenfeld, Helena Alexandra Yu, Gregory J Riely, Shinichi Toyooka, Christine M Lovly, Paul K Paik, Marc Ladanyi, Pang-Dian Fan
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors. JCO precision oncology 6 (2022)
Debyani Chakravarty, Amber M Johnson, Jeffrey Sklar, Neal I Lindeman, Kathleen M Moore, Shridar Ganesan, Christine M Lovly, Jane Perlmutter, Stacy W Gray, Jimmy Hwang, Christopher H Lieu, Fabrice Andre, Nilofer S Azad, Mitesh J Borad, Laura Tafe, Hans Messersmith, Mark E Robson, Funda Meric-Bernstam
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Zhenfang Du, Benjamin P Brown, Soyeon Kim, Donna Ferguson, Dean C Pavlick, Gowtham Jayakumaran, Ryma Benayed, Jean-Nicolas Gallant, Yun-Kai Zhang, Yingjun Yan, Monica Red-Brewer, Siraj M Ali, Alexa B Schrock, Ahmet Zehir, Marc Ladanyi, Adam W Smith, Jens Meiler, Christine M Lovly
Structure-function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting. Nature communications 12 (1) (2021)
Erin M Wilfong, Christine M Lovly, Erin A Gillaspie, Li-Ching Huang, Yu Shyr, Jonathan Dale Casey, Brian I Rini, Matthew W Semler
Severity of illness scores at presentation predict ICU admission and mortality in COVID-19. Journal of emergency and critical care medicine (Hong Kong, China) 5 (2021)
Christine M Lovly, Kelli L Boyd, Paula I Gonzalez-Ericsson, Cindy L Lowe, Hunter M Brown, Robert D Hoffman, Brent C Sterling, Meghan E Kapp, Douglas B Johnson, Prasad R Kopparapu, Wade T Iams, Melissa A Warren, Michael J Noto, Brian I Rini, Madan Jagasia, Suman R Das, Justin M Balko
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer. medRxiv : the preprint server for health sciences (2020)
Jean-Nicolas Gallant, Christine M Lovly
Established, emerging and elusive molecular targets in the treatment of lung cancer. The Journal of pathology 244 (5) (2018)

Christine M Lovly.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christine M Lovly